Loading...
HomeMy WebLinkAboutResolution - 2023-R0132 - Award Number 1 NU58DP007289-01-00 with DSHS and CDCResolution No. 2023-RO132 Item No. 6.23 March 7, 2023 RESOLUTION BE IT RESOLVED BY THE CITY COUNCIL OF THE CITY OF LUBBOCK: THAT the acts of the Mayor of the City of Lubbock in executing, on behalf of the City of Lubbock, Award Number 1 NU58DP007289-01-00, "A collaborative approach to addressing the social determinants of health in west Texas," by and between the City of Lubbock and the United States Department of Health and Human Services acting by and through the Center for Disease Control and Prevention, and all related documents are hereby ratified in full. Said Award is attached hereto and incorporated in this resolution as if fully set forth herein and shall be included in the minutes of the City Council. Passed by the City Council on TTEST: IZV71t/ V Courtney Paz, In erim ity Secretary APPROVED AS TO CONTENT: /l ✓ e ) a �IM-MA r Bill Howe puty City Mana APPROVED AS TO FO Ryan 4Koke, Assistant City Attorney March 7, 2023 Q�7� TRAY" AYOR RES.USDHHS-CDC Award No. 1 NU58DP007289-01-00 2.16.23 Resolution No. 2023-R0132 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention �.w Recipient Information 1. Recipient Name LUBBOCK, CITY OF 1314 Avenue K Lubbock, TX 79401-4051 [No Phone Record] 2. Congressional District of Recipient 19 3. Payment System Identifier (ID) 1756000590AI 4. Employer Identification Number (EIN) 756000590 5. Data Universal Numbering System (DUNS) 058213893 6. Recipient's Unique Entity Identifier (UEI) LXDNEKWRVKI6 7. Project Director or Principal Investigator Madeline Geeslin mmcclure;u mylubbock.us 8067753091 8. Authorized Official Mr. Tray Payne traypayne kmylubbock.us 806-775-2010 Federal Agency Information CDC Office of Financial Resources 9. Awarding Agency Contact Information Reginald Simpson Grants Management Specialist sgv8(q cdc.gov 678-475-4971 10.Program Official Contact Information Antwuanette Daniel Program Support Staff nty3;ri cdc.gov 4046394740 30. Remarks Notice of Award Award# 1 NU58DP007289-01-00 FAIN# NU58DP007289 Federal Award Date: 09/09 2022 Federal Award Information 11. Award Number 1 NU58DP007289-01-00 12. Unique Federal Award Identification Number (FAIN) NU58DP007289 13. Statutory Authority Public Health Service Act, as amended, Section 301(a) and Section 317K, 42 U.S.C. 241(a); 42 U.S.C. 247b- 12 14. Federal Award Project Title A collaborative approach to addressing the social determinants of health in west Texas 15. Assistance Listing Number 93.945 16. Assistance Listing Program Title Assistance Programs for Chronic Disease Prevention and Control 17. Award Action Type New 18. Is the Award R&D? No Summary Federal Award Financial Information 19. Budget Period Start Date 09 30 2022 - End Date 09 29 2023 20. Total Amount of Federal Funds Obligated by this Action $125,000.00 20a. Direct Cost Amount $125,000.00 20b. Indirect Cost Amount $0.00 21. Authorized Carryover $0.00 22. Offset $0.00 23. Total Amount of Federal Funds Obligated this budget period $0.00 24. Total Approved Cost Sharing or Matching, where applicable $0.00 25. Total Federal and Non -Federal Approved this Budget Period $125,000.00 26. Period of Perfomance Start Date 09`30/2022 - End Date 09/29 2027 27. Total Amount of the Federal Award including Approved Cost Sharing or Matching this Period of Performance $125,000.00 28. Authorized Treatment of Program Income ADDITIONAL COSTS 29. Grants Management Officer - Signature Ms. Pamela Render Grants Management Officer Page 1 SO DEPARTMENT OF HEALTH AND HUMAN SERVICES g Centers for Disease Control and Prevention JA" �4 q Recipient Information Recipient Name LUBBOCK, CITY OF 1314 Avenue K Lubbock, TX 79401-4051 [No Phone Record] Congressional District of Recipient 19 Payment Account Number and Type 1756000590A 1 Employer Identification Number (EIN) Data 756000590 Universal Numbering System (DUNS) 058213893 Recipient's Unique Entity Identifier (UEI) LXDNEKWRVKJ6 31. Assistance Type Project Grant 32. Type of Award Other 1 34. Accounting Classification Codes Notice of Award Award# 1 NU58DP007289-01-00 FAIN# NU58DP007289 Federal Award Date: 09/09/2022 33. Approved Budget (Excludes Direct Assistance) I. Financial Assistance from the Federal Awarding Agency Only II. Total project costs including grant funds and all other financial participation a. Salaries and Wages $30,000.00 b. Fringe Benefits $0.00 c. Total PersonnelCosts $30,000.00 d. Equipment $0.00 e. Supplies $10,000.00 E Travel $17,000.00 g. Construction $0.00 h. Other $18,000.00 i. Contractual $50,000.00 j. TOTAL DIRECT COSTS $125,0001— IL INDIRECT COSTS $0.00 1. TOTAL APPROVED BUDGET $125,000.00 m. Federal Share $125,000 00 n. Non -Federal Share $0.00 FY-ACCOUNT NO. DOCUMENT NO. ADMINISTRATIVE CODE OBJECT CLASS CFDA NO. AMT ACTION FINANCIAL ASSISTANCE IAPPROPRIATION 2-9390JWG 22NU58DP007289 DP 41.51 93.945 S125,000.00 75-22-0948 Page 2 f� DEPARTMENT OF HEALTH AND HUMAN SERVICES Notice of Award `+ Centers for Disease Control and Prevention Award# 1 NU58DP007289-01-00 r1°� ti FAIN# NU58DP007289 Federal Award Date: 09/09/2022 Direct Assistance BUDGET CATEGORIES PREVIOUS AMOUNT (A) AMOUNT THIS ACTION (S) TOTAL (A + B) Personnel $0.00 $0.00 Fringe Benefits$0.00 $0.00 —$0.00 $0.00 Travel $0.00 $0.00 $0.00 Equipment $0.00 $0.00 $0.00 Supplies $0.00 $0.00 $0.00 Contractual $0.00 $0.00 $0.00 Construction $0.00 $0.00 $0.00 Other $0.00 $0.00 $0.00 Total $0.00 $0.00 $0.00 Page 3 AWARD ATTACHMENTS LUBBOCK, CITY OF 1. Year 01 Terms and Conditions 1 NU58DP007289-01-00 10Office C() of Financial Resources FR Office of Grants Services (OGS) AWARD INFORMATION Services. Support. Solutions. Incorporation: In addition to the federal laws, regulations, policies, and CDC General Terms and Conditions for Non -research awards at https://www.cdc.gov/grants/federal-repulations- policies/index.html, the Centers for Disease Control and Prevention (CDC) hereby incorporates Notice of Funding Opportunity (NOFO) number CDC-RFA-DP22-2210, entitled Closing the Gap with Social Determinant of Health Accelerarators Plans, and application dated July 8, 2022, as may be amended, which are hereby made a part of this Non -research award, hereinafter referred to as the Notice of Award (NoA). Approved Funding: Funding in the amount of $125,000 is approved for the Year 01 budget period, which is September 30, 2022 through September 29, 2023. All future year funding will be based on satisfactory programmatic progress and the availability of funds. The federal award amount is subject to adjustment based on total allowable costs incurred and/or the value of any third party in -kind contribution when applicable. Note: Refer to the Payment Information section for Payment Management System (PMS) subaccount information. Financial Assistance Mechanism: Grant Budget Revision Requirement: By October 31, 2022, the recipient must submit a revised budget with a narrative justification. Please use the link below for the level of detail that is required for your budget revision:https://www.cdc.gov/grants/documents/budget-r)reparation- guidance.pdf Failure to submit the required information in a timely manner may adversely affect the future funding of this project. If the information cannot be provided by the due date, you are required to contact the GMS/GMO identified in the CDC Staff Contacts section of this notice before the due date. FUNDING RESTRICTIONS AND LIMITATIONS Notice of Funding Opportunity (NOFO) Restrictions: Restrictions that must be considered while planning the programs and writing the budget are: • Recipients may not use funds for research. • Recipients may not use funds for clinical care except as allowed by law. • Recipients may use funds only for reasonable program purposes, including personnel, travel, supplies, and services. • Generally, recipients may not use funds to purchase furniture or equipment. Any such proposed spending must be clearly identified in the budget. • Reimbursement of pre -award costs generally is not allowed, unless the CDC provides written approval to the recipient. • Other than for normal and recognized executive -legislative relationships, no funds may be used for: o publicity or propaganda purposes, for the preparation, distribution, or use of any material designed to support or defeat the enactment of legislation before any legislative body o the salary or expenses of any grant or contract recipient, or agent acting for such recipient, related to any activity designed to influence the enactment of legislation, appropriations, regulation, administrative action, or Executive order proposed or pending before any legislative body See Additional Requirement (AR) 12 for detailed guidance on this prohibition and additional guidance on lobbying for CDC recipients. The direct and primary recipient in a cooperative agreement program must perform a substantial role in carrying out project outcomes and not merely serve as a conduit for an award to another party or provider who is ineligible. Indirect Costs: Indirect Costs are not requested as a provision of this award REPORTING REQUIREMENTS Required Disclosures for Federal Awardee Performance and Integrity Information System (FAPIIS): Consistent with 45 CFR 75.113, applicants and recipients must disclose in a timely manner, in writing to the CDC, with a copy to the HHS Office of Inspector General (OIG), all information related to violations of federal criminal law involving fraud, bribery, or gratuity violations potentially affecting the federal award. Subrecipients must disclose, in a timely manner in writing to the prime recipient (pass through entity) and the HHS OIG, all information related to violations of federal criminal law involving fraud, bribery, or gratuity violations potentially affecting the federal award. Disclosures must be sent in writing to the CDC and to the HHS OIG at the following addresses: CDC, Office of Grants Services Pamela Render, Grants Management Officer Centers for Disease Control and Prevention Branch 5 Supporting Chronic Diseases and Injury Prevention Email: p1r3(@cdc.gov (Include "Mandatory Grant Disclosures" in subject line) UO-31 U.S. Department of Health and Human Services Office of the Inspector General ATTN: Mandatory Grant Disclosures, Intake Coordinator 330 Independence Avenue, SW Cohen Building, Room 5527 Washington, DC 20201 Fax: (202)-205-0604 (Include "Mandatory Grant Disclosures" in subject line) or Email: MandatoryGranteeDisclosures(&oig.hhs.gov Recipients must include this mandatory disclosure requirement in all subawards and contracts under this award. Failure to make required disclosures can result in any of the remedies described in 45 CFR 75.371. Remedies for noncompliance, including suspension or debarment (See 2 CFR parts 180 and 376, and 31 U.S.C. 3321). Last Updated September 2021, Page 2 of 3 CDC is required to report any termination of a federal award prior to the end of the period of performance due to material failure to comply with the terms and conditions of this award in the OMB -designated integrity and performance system accessible through SAM (currently FARIS). (45 CFR 75.372(b)) CDC must also notify the recipient if the federal award is terminated for failure to comply with the federal statutes, regulations, or terms and conditions of the federal award. (45 CFR 75.373(b)) PAYMENT INFORMATION The HHS Office of the Inspector General (OIG) maintains a toll -free number (1-800-HHS-TIPS [1- 800-447-8477]) for receiving information concerning fraud, waste, or abuse under grants and cooperative agreements. Information also may be submitted by a -mail to hhstipse-oig.hhs.gov or by mail to Office of the Inspector General, Department of Health and Human Services, Attn: HOTLINE, 330 Independence Ave., SW, Washington DC 20201. Such reports are treated as sensitive material and submitters may decline to give their names if they choose to remain anonymous. Payment Management System Subaccount: Funds awarded in support of approved activities have been obligated in a subaccount in the PMS, herein identified as the "P Account'. Funds must be used in support of approved activities in the NOFO and the approved application. The grant document number identified beginning on the bottom of Page 2 of the Notice of Award must be known in order to draw down funds. Last Updated September 2021, Page 3 of 3